QT Imaging (QTI) vs Stereotaxis (STXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Stereotaxis (STXS) has outperformed QT Imaging (QTI) over the past year, losing 67.1% versus a loss of 92.0%. Stereotaxis is the larger company by market cap ($111.2 million vs $39.2 million), about 2.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QTI | STXS |
|---|---|---|
| Share price | $2.68 | $1.11 |
| Market cap | $39.23M | $111.22M |
| 1-day change | +3.08% | 0.00% |
| YTD return | -56.07% | -51.74% |
| 1-year return | -91.99% | -67.06% |
| 5-year return | — | -81.28% |
| EPS (TTM) | $-1.40 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $36.75 | $3.20 |
| 52-week low | $2.42 | $1.09 |
| Distance from 52-week high | -92.71% | -65.31% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +288.06% | +170.27% |
| Average volume | 36.92K | 805.99K |
| Shares outstanding | 14.64M | 100.20M |
| Employees | 31 | 131 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stereotaxis is about 2.8 times larger than QT Imaging by market value ($111.22M vs $39.23M).
- STXS has outperformed QTI by 24.9 percentage points over the past year.
About QT Imaging
QTI stock →QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 31 employees
About Stereotaxis
STXS stock →Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 131 employees
QTI vs STXS FAQ
Which is bigger, QT Imaging or Stereotaxis?
Stereotaxis (STXS) is larger, with a market capitalization of $111.22M compared with $39.23M for QT Imaging (QTI).
Which stock has performed better over the past year, QTI or STXS?
STXS returned -67.06% over the past 12 months, compared with -91.99% for QTI (price return, excluding dividends). Past performance does not predict future results.
Are QT Imaging and Stereotaxis in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.